Author

Scott McKinnon

University of SheffieldORCID 0000-0001-9535-7456Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Pamela J. ShawiD· 2 shared Richard J. MeadiD· 2 shared Tyler R. WellsiD· 2 shared Alex Daniel· 1 shared Allan Christian ShawiD· 1 shared Amy F. A. KeerieiD· 1 shared Amy F. Keerie· 1 shared Chloe F. AlleniD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Pamela J. ShawORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintDec 8, 2024

M102, a combined NRF2 and HSF-1 activator for neuroprotection in amyotrophic lateral sclerosis.

Amy F. Keerie, Raquel Rua Martins, Chloe F. Allen…·Richard J. Mead

M102, a dual NRF2/HSF1 activator, slows disease progression in 2 mouse models and exerts neuroprotection in human cellular models of ALS.

2 citations

mouseexperimental assay

𝕏 PostBluesky

NeurosciencebioRxivPreprintMay 9, 2024

Maximising the translational potential of neurophysiology in amyotrophic lateral sclerosis: a study on compound muscle action potentials

Scott McKinnon, Zekai Qiang, Amy F. A. Keerie…·Richard J. Mead

This study compares compound muscle action potentials (CMAPs) in SOD1G93A mice and human ALS patients to identify translational alignment points for disease progression.

DOI 10.1101/2024.05.09.593349

𝕏 PostBluesky